Icd Primary Prevention denied as experimental or investigational by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for icd primary prevention are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UHC Labels Primary-Prevention ICD as Experimental — and Why You Can Appeal

A denial categorizing a primary-prevention implantable cardioverter-defibrillator (ICD) as "experimental or investigational" is legally and clinically significant — and often overturned on appeal. Primary-prevention ICD implantation for patients at elevated sudden cardiac death risk has been endorsed by major cardiovascular guideline organizations for many years and is FDA-approved for its indicated uses. An experimental denial at UnitedHealthcare typically means the plan's medical policy has a specific coverage criterion your file has not yet addressed, or that the clinical documentation has not adequately established that your situation falls within the covered (non-experimental) parameters.

## Your Federal Appeal Rights

Under ACA §2719, fully-insured plan members are entitled to external review of adverse benefit determinations — including experimental denials — by an accredited independent review organization. External review must generally be requested within four months of the final internal denial. ERISA §503 provides self-funded plan participants a full-and-fair review right. Experimental denials are among the most commonly reversed at external review when the treatment at issue has established guideline support.

## Concrete Appeal Process

1. Request the full denial letter identifying the specific experimental/investigational criterion cited and the UHC coverage policy number. 2. Download UHC's ICD coverage determination guideline and identify the exact language distinguishing covered from non-covered (experimental) indications. 3. File Level 1 internal appeal with documentation establishing guideline-concordant clinical criteria. 4. Escalate to Level 2 if upheld, then to external review by an IRO.

## Documentation to Gather

• Cardiac imaging and functional assessment: echocardiogram reports, cardiac MRI (if performed), and any nuclear or catheterization data relevant to the primary-prevention risk determination.
• Electrophysiology evaluation: EP consultation notes, Holter or event monitor data, and any prior arrhythmia episodes.
• Guideline concordance letter: a letter from your cardiologist or electrophysiologist citing the applicable ACC/AHA/HRS guideline organization's recommendations for primary-prevention ICD implantation and mapping your clinical profile to those guidelines without inventing specific numbers.
• FDA clearance documentation: if the denial asserts the device itself is experimental, provide the device's FDA 510(k) or PMA clearance reference.

## Criteria-Mapping Structure

| UHC Experimental Criterion (verbatim) | Evidence Establishing Non-Experimental, Covered Status | |---|---| | [Paste policy language] | [Chart data, imaging result, guideline reference, FDA clearance] |